Search Count: 14
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 L94C Variant In Complex With Racemic 3,5-Dimethylisoxazol Ligand
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2023-08-02 Classification: GENE REGULATION Ligands: E5Q, V0R |
 |
Crystal Structure Of Trim33 Phd-Bromodomain Isoform B In Complex With H3K10Ac Histone Peptide.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2022-06-29 Classification: TRANSCRIPTION Ligands: EDO, ZN |
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With A 3,5-Dimethylisoxazol Ligand
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.34 Å Release Date: 2018-04-18 Classification: TRANSCRIPTION Ligands: EDO, E5Q |
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With A 3,5-Dimethylisoxazol Ligand
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.28 Å Release Date: 2018-04-18 Classification: TRANSCRIPTION Ligands: EDO, E5T |
 |
Crystal Structure Of The First Bromodomain Of Human Brd4 In Complex With A 3,5-Dimethylisoxazol Ligand
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.34 Å Release Date: 2018-04-18 Classification: TRANSCRIPTION Ligands: E5W |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2014-12-24 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q8 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q9 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: FGH |
 |
Identification Of Novel Hsp90 / Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2R6 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2QA |
 |
Crystal Structure Of Cholesteryl Ester Transfer Protein In Complex With Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2012-09-05 Classification: LIPID TRANSPORT/INHIBITOR Ligands: 2OB, DLP, PGE, CL, 0RP |
 |
Crystal Structure Of Cholestryl Esters Transfer Protein In Complex With Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.11 Å Release Date: 2012-09-05 Classification: LIPID TRANSPORT/INHIBITOR Ligands: 2OB, PCW, PGE, CL, 0SF |
 |
Organism: Enterobacteria phage t7
Method: SOLUTION NMR Release Date: 2010-02-16 Classification: HYDROLASE |
 |
Identification And Characterization Of A Small Molecule Inhibitor Of Fatty Acid Binding Proteins
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2009-09-22 Classification: PROTEIN BINDING Ligands: B64 |